Related Experiment Video
Updated: Mar 16, 2026

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury
Published on: November 28, 2025
An algorithm for rule-in and rule-out of acute myocardial infarction using a novel troponin I assay
Bertil Lindahl1, Tomas Jernberg2,3, Patrick Badertscher4
1Department of Medical Sciences and Uppsala Clinical Research Center, Uppsala, University, Uppsala, Sweden.
Insights
A new algorithm using cardiac troponin I (cTnI) effectively rules in or out acute myocardial infarction in chest pain patients. This rapid, two-step approach improves diagnostic speed while maintaining high accuracy for rule-out and rule-in decisions.
Area of Science:
- Cardiology
- Biochemistry
- Emergency Medicine
Background:
- Acute myocardial infarction (AMI) diagnosis relies on timely and accurate risk stratification.
- Current diagnostic protocols for chest pain patients in the emergency department can be lengthy.
- Novel biomarkers and algorithms are needed to expedite AMI rule-out and rule-in.
Purpose of the Study:
- To develop and validate a hybrid algorithm for AMI rule-out and rule-in.
- To utilize a novel cardiac troponin I (cTnI) assay for serial measurements.
- To assess the algorithm's performance at presentation and after 2 hours in emergency department patients.
Main Methods:
- Algorithm derivation and validation in two multicenter cohorts totaling 1197 chest pain patients.
- Inclusion criteria: emergency department presentation with symptom onset within 12 hours.
- Independent adjudication of index diagnosis and 30-day cardiovascular events.
Main Results:
- At presentation, 32.6% were ruled out, 6.1% ruled in; after 2 hours, an additional 22% were ruled out and 9.8% ruled in.
- Overall, 54.6% ruled out (NPV 99.4%), 15.8% ruled in (PPV 74.5%).
- High diagnostic performance achieved with no deaths in the rule-out group during 30-day follow-up.
Conclusions:
- A novel two-step algorithm using cTnI measurements efficiently manages acute chest pain patients.
- The algorithm enables rapid rule-in/rule-out decisions, with over a third of patients classified at presentation and another third after 2 hours.
- This strategy balances diagnostic speed with high negative and positive predictive values.
Objective:
To derive and validate a hybrid algorithm for rule-out and rule-in of acute myocardial infarction based on measurements at presentation and after 2 hours with a novel cardiac troponin I (cTnI) assay.
Methods:
The algorithm was derived and validated in two cohorts (605 and 592 patients) from multicentre studies enrolling chest pain patients presenting to the emergency department (ED) with onset of last episode within 12 hours. The index diagnosis and cardiovascular events up to 30 days were adjudicated by independent reviewers.
Results:
In the validation cohort, 32.6% of the patients were ruled out on ED presentation, 6.1% were ruled in and 61.3% remained undetermined. A further 22% could be ruled out and 9.8% ruled in, after 2 hours. In total, 54.6% of the patients were ruled out with a negative predictive value (NPV) of 99.4% (95% CI 97.8% to 99.9%) and a sensitivity of 97.7% (95% CI 91.9% to 99.7%); 15.8% were ruled in with a positive predictive value (PPV) of 74.5% (95% CI 64.8% to 82.2%) and a specificity of 95.2% (95% CI 93.0% to 96.9%); and 29.6% remained undetermined after 2 hours. No patient in the rule-out group died during the 30-day follow-up in the two cohorts.
Conclusions:
This novel two-step algorithm based on cTnI measurements enabled just over a third of the patients with acute chest pain to be ruled in or ruled out already at presentation and an additional third after 2 hours. This strategy maximises the speed of rule-out and rule-in while maintaining a high NPV and PPV, respectively.
More Related Videos
10:01Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
Published on: March 12, 2018
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome IV: Interprofessional Care